Skip to content

Polyphron raised $20 million in a seed round led by Quiet Capital, announced Oct. 8.

Facts

Company
Polyphron
Amount
$20 million
Currency
USD
Stage
Seed
Announced
Oct 8, 2026

Investors

Use of funds

Scaling the core infrastructure, expanding the training dataset, building automation, and growing the donor panel.

As stated by the company.

Sources

  1. 1.Polyphron Raises $20M to Predict Drug Toxicity in Human Tissue Before Clinical Trials — AlleyWatch, Oct 9, 2026

Public sources — Collected from public sources, not yet cross-checked.Last verified Oct 15, 2026